PMID- 25733460 OWN - NLM STAT- MEDLINE DCOM- 20150427 LR - 20230216 IS - 1541-6100 (Electronic) IS - 0022-3166 (Linking) VI - 145 IP - 3 DP - 2015 Mar TI - Sugar-sweetened product consumption alters glucose homeostasis compared with dairy product consumption in men and women at risk of type 2 diabetes mellitus. PG - 459-66 LID - 10.3945/jn.114.204503 [doi] AB - BACKGROUND: Dietary patterns characterized by high intakes of fruits and vegetables, whole grains, low-fat dairy products, and low glycemic load have been associated with lower type 2 diabetes mellitus (T2DM) risk. In contrast, dietary patterns that include high intakes of refined grains, processed meats, and high amounts of added sugars have been associated with increased T2DM risk. OBJECTIVE: This randomized, 2-period crossover trial compared the effects of dairy and sugar-sweetened product (SSP) consumption on insulin sensitivity and pancreatic beta-cell function in men and women at risk of the development of T2DM who habitually consume sugar-sweetened beverages. METHODS: In a randomized, controlled crossover trial, participants consumed dairy products (474 mL/d 2% milk and 170 g/d low-fat yogurt) and SSPs (710 mL/d nondiet soda and 108 g/d nondairy pudding), each for 6 wk, with a 2-wk washout between treatments. A liquid meal tolerance test (LMTT) was administered at baseline and the end of each period. RESULTS: Participants were 50% female with a mean age and body mass index of 53.8 y and 32.2 kg/m(2), respectively. Changes from baseline were significantly different between dairy product and SSP conditions for median homeostasis model assessment 2-insulin sensitivity (HOMA2-%S) (1.3 vs. -21.3%, respectively, P = 0.009; baseline = 118%), mean LMTT disposition index (-0.03 vs. -0.36, respectively, P = 0.011; baseline = 2.59), mean HDL cholesterol (0.8 vs. -4.2%, respectively, P = 0.015; baseline = 44.3 mg/dL), and mean serum 25-hydroxyvitamin D [25(OH)D] (11.7 vs. -3.3, respectively, P = 0.022; baseline = 24.5 mug/L). Changes from baseline in LMTT Matsuda insulin sensitivity index (-0.10 vs. -0.49, respectively; baseline = 4.16) and mean HOMA2-beta-cell function (-2.0 vs. 5.3%, respectively; baseline = 72.6%) did not differ significantly between treatments. CONCLUSION: These results suggest that SSP consumption is associated with less favorable values for HOMA2-%S, LMTT disposition index, HDL cholesterol, and serum 25(OH)D in men and women at risk of T2DM vs. baseline values and values during dairy product consumption. This trial was registered at clinicaltrials.gov as NCT01936935. CI - (c) 2015 American Society for Nutrition. FAU - Maki, Kevin C AU - Maki KC AD - Biofortis Clinical Research, Addison, IL; and Midwest Center for Metabolic and Cardiovascular Research, Glen Ellyn, IL kmaki@mc-mcr.com. FAU - Nieman, Kristin M AU - Nieman KM AD - Biofortis Clinical Research, Addison, IL; and. FAU - Schild, Arianne L AU - Schild AL AD - Biofortis Clinical Research, Addison, IL; and. FAU - Kaden, Valerie N AU - Kaden VN AD - Biofortis Clinical Research, Addison, IL; and. FAU - Lawless, Andrea L AU - Lawless AL AD - Biofortis Clinical Research, Addison, IL; and. FAU - Kelley, Kathleen M AU - Kelley KM AD - Biofortis Clinical Research, Addison, IL; and. FAU - Rains, Tia M AU - Rains TM AD - Biofortis Clinical Research, Addison, IL; and. LA - eng SI - ClinicalTrials.gov/NCT01936935 PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20150107 PL - United States TA - J Nutr JT - The Journal of nutrition JID - 0404243 RN - 0 (Blood Glucose) RN - 0 (Cholesterol, HDL) RN - 0 (Cholesterol, LDL) RN - 0 (Dietary Sucrose) RN - 0 (Insulin) RN - 0 (Nutritive Sweeteners) RN - 0 (Triglycerides) RN - 1406-16-2 (Vitamin D) SB - IM MH - Blood Glucose/*metabolism MH - Body Mass Index MH - Cholesterol, HDL/blood MH - Cholesterol, LDL/blood MH - Cross-Over Studies MH - Dairy Products MH - Diabetes Mellitus, Type 2/blood/diet therapy/*prevention & control MH - Dietary Sucrose/*administration & dosage MH - *Feeding Behavior MH - Female MH - *Homeostasis MH - Humans MH - Insulin/blood MH - Insulin Resistance MH - Insulin-Secreting Cells/metabolism MH - Male MH - Middle Aged MH - Nutritive Sweeteners/administration & dosage MH - Risk Factors MH - Triglycerides/blood MH - Vitamin D/blood OTO - NOTNLM OT - Insulin sensitivity OT - dairy OT - lipoproteins OT - sugars OT - type 2 diabetes mellitus EDAT- 2015/03/04 06:00 MHDA- 2015/04/29 06:00 CRDT- 2015/03/04 06:00 PHST- 2015/03/04 06:00 [entrez] PHST- 2015/03/04 06:00 [pubmed] PHST- 2015/04/29 06:00 [medline] AID - S0022-3166(22)08647-3 [pii] AID - 10.3945/jn.114.204503 [doi] PST - ppublish SO - J Nutr. 2015 Mar;145(3):459-66. doi: 10.3945/jn.114.204503. Epub 2015 Jan 7.